↓ Skip to main content

Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma

Overview of attention for article published in Frontiers in immunology, February 2024
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
4 Mendeley